2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Clinical genetics<br />
roborate the existence <strong>of</strong> a clinically recognizable group <strong>of</strong> AOS patients<br />
with psychomotor delay, mental retardation, central nervous system<br />
(CNS) manifestations and seizures . Furthermore, subependymal<br />
heterotopia, never reported before in AOS, broadens the phenotypic<br />
spectrum <strong>of</strong> CNS abnormalities to include neuronal migration defects .<br />
This severe variant <strong>of</strong> AOS, whose phenotype has been recently delineated,<br />
is likely inherited in autosomal recessive fashion . Hence, the<br />
importance <strong>of</strong> a timely diagnosis not only to manage CNS manifestations<br />
but also to properly counsel the families .<br />
P01.240<br />
Aplasia cutis congenita type iii, congenital scalp defects with<br />
distal limb reduction anomalies - Adams-Olivier syndrome.<br />
J. Paprocka 1 , E. Jamroz 1 , A. Pyrkosz 2 , A. Jezela-Stanek 3 , S. Hacia 4 , J. Baron 4 ,<br />
E. Marszał 1 ;<br />
1 Child Neurology Department, Silesian Medical University, Katowice 40-752,<br />
Poland, 2 Department <strong>of</strong> Molecular Biology and <strong>Genetics</strong>, Silesian Medical University,<br />
Katowice 40-752, Poland, 3 Department <strong>of</strong> Clinical <strong>Genetics</strong>, Memorial<br />
Children’s Health Institute, Warsaw, Poland, 4 Student’s Association at the Child<br />
Neurology Department, Silesian Medical University, Katowice 40-752, Poland.<br />
Aplasia cutis congenita (ACC) are the heterogeneous group <strong>of</strong> disorders<br />
with various clinical manifestations . Adams-Oliver syndrome<br />
(AOS, MIM 100300), a rare congenital disorder, belongs to the type III<br />
by Sybert classification <strong>of</strong> ACC, and is characterized by aplasia cutis<br />
congenita <strong>of</strong> the scalp and variable degrees <strong>of</strong> terminal transverse limb<br />
defects . Other associated anomalies include vascular defects: cutis<br />
marmorata, dilated scalp veins, small eyes, hypoplastic optic nerve,<br />
submucous cleft palate, cardiovascular and brain malformations (cortical<br />
malformations- polymicrogyria, encephalocoele, hypoplasia <strong>of</strong> the<br />
left arteria cerebri media) .<br />
Adams-Oliver syndrome is a genetic defect that causes a vasculopathy<br />
and leads to a variety <strong>of</strong> phenotypes . Inheritance <strong>of</strong> Adams-Olivier<br />
syndrome is autosomal dominant but there are also reports <strong>of</strong> possible<br />
autosomal recessive mode <strong>of</strong> inheritance .<br />
The authors present a 27-month-old-boy with phenotype <strong>of</strong> Adams-Olivier<br />
syndrome and Peter’s anomaly (central leukomata with variable<br />
iridocorneal and keratolenticular adhesions and cataract), refractory<br />
epilepsy and psychomotor retardation . The molecular investigation is<br />
ongoing in order to identify the genetic cause <strong>of</strong> AOS .<br />
P01.241<br />
manifestation <strong>of</strong> X-linked Adrenoleukodystrophy in<br />
heterozygous carriers<br />
S. V. Mikhaylova 1 , G. E. Rudenskaya 2 , N. Y. Kalinchenko 3 , O. V. Shekhter 2 ;<br />
1 Russian Children’s Hospital, Moscow, Russian Federation, 2 Research Centre<br />
for Medical <strong>Genetics</strong>, Moscow, Russian Federation, 3 Endocrinological Research<br />
Center, Moscow, Russian Federation.<br />
X-linked adrenoleukodystrophy (ALD, MIM 300100) has several phenotypes,<br />
clinical manifestation in women-heterozygous carriers among<br />
them . About 15_20% <strong>of</strong> carriers develop neurological signs, typically<br />
lower spastic paraparesis resembling adrenomyeloneuropathy (AMN)<br />
without adrenal insufficiency. After 40 yrs this proportion amounts<br />
50% . Though, ALD manifestation is women is <strong>of</strong>ten misdiagnosed . In<br />
our sample <strong>of</strong> 50 unrelated families with verified ALD there were two<br />
families with evident manifestation in women . Low proportion <strong>of</strong> these<br />
cases may be partly due to the young age <strong>of</strong> most mothers in the<br />
sample . In one family, 7-year-old proband had childhood cerebral ALD,<br />
in his younger brother presymptomatic stage <strong>of</strong> disease was found<br />
out . Their 26-year-old maternal uncle showed typical presentations <strong>of</strong><br />
AMN, 52-year-old grandmother had progressive spastic paraparesis<br />
since 35_40 yrs . Prior to ALD discovering in the proband they had diagnosis<br />
<strong>of</strong> Strumpell’s disease despite evident adrenal insufficiency in<br />
the uncle . In 3-year-old proband from another family ALD manifested<br />
by adrenal insufficiency as early as in 2.5 yrs, brain MRI proved childhood<br />
cerebral form . His 32-year-old mother and her monozygotic twin<br />
since 27 yrs suffered spastic paraparesis with bladder disturbances<br />
and normal MRI, their previous diagnosis was multiple sclerosis . Such<br />
cases along with reported earlier [Krenn et al, 2001; O’Neill et al, 2001;<br />
Shaw-Smith et al, 2004] point that women suspicious for Strumpell’s<br />
disease or familial multiple sclerosis should be tested for ALD if pedigree<br />
permits X-linked inheritance. Both families, particularly the first<br />
one, also support the known fact <strong>of</strong> diffferent ALD phenotypes intrafamilial<br />
co-existence .<br />
P01.242<br />
New mutations and sequence variations in galician patients with<br />
familiar Alzheimer´s Desease<br />
M. Garcia-Murias 1 , A. Robles 2 , G. Martínez-Nieto 1 , M. Arias 2 , A. Koukoulis 3 , B.<br />
Quintáns 4,5 , P. Blanco-Arias 6,5 , A. Sesar 2 , A. Carracedo 1,6,5 , M. Sobrido 1,5 ;<br />
1 Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela,<br />
Spain, 2 Department <strong>of</strong> Neurology, Hospital Clínico, Santiago de Compostela,<br />
Spain, 3 Department <strong>of</strong> Neurology, Hospital Xeral-Cíes, Vigo, Spain, 4 Hospital<br />
Clínico-SERGAS, Santiago de Compostela, Spain, 5 Centro Para Investigación<br />
en Red de Enfermedades Raras CIBERER, ISCIII, Santiago de Compostela,<br />
Spain, 6 Grupo de Medicina Xenómica-USC, Santiago de Compostela, Spain.<br />
Mutations in presenilin 1 (PSEN1) are detected in 30-70% <strong>of</strong> familiar<br />
Alzheimer disease (FAD) while presenilin 2 (PSEN2) and amyloid precursor<br />
protein (APP) mutations are much less frequent . We studied 61<br />
clinical-based cases with a diagnosis <strong>of</strong> probable FAD . We sequenced<br />
all coding exons <strong>of</strong> PSEN1 and PSEN2, as well as exons 16 and 17<br />
<strong>of</strong> APP on an ABI3730 sequencer . Sequence analysis was performed<br />
with the Staden package. A novel L424V mutation was identified in<br />
exon 12 <strong>of</strong> PSEN1 in a patient with very young onset dementia . Another<br />
new mutation, I408T, was identified in exon 11 <strong>of</strong> PSEN1 in a<br />
family . In two other cases <strong>of</strong> FAD missense mutations were detected in<br />
PSEN2: A415T and R435Q, both in exon 12 . Five patients showed intronic<br />
changes <strong>of</strong> unknown significance not reported in the searchable<br />
databases if human polymorphisms. We identified the single nucleotide<br />
substitution c .338+39G>A in intron 4 <strong>of</strong> PSEN1, a 6 bp deletion in<br />
intron 17 <strong>of</strong> APP and three intronic variants in PSEN2: c .119-31G>A<br />
(intron 4), c .887-19A>C (intron 8), c .1191+57T>A (intron 11) . A synonymous<br />
change (S236S) in PSEN2 was present in two individuals . All<br />
new mutations and sequence variations were screened in a panel <strong>of</strong><br />
186 Galician control individuals without neurological disorders . Globally<br />
mutations were detected in 6 .6% <strong>of</strong> the cases (18% if we consider<br />
both missense mutations and sequence variations <strong>of</strong> unknown significance)<br />
. This low frequency <strong>of</strong> mutations may be due to not very restrictive<br />
referring criteria . Alternatively, other genes may explain most FAD<br />
in our region .<br />
P01.243<br />
Left Ventricular Outflow Tract Obstructions (LVOTO): family data<br />
and NOTCH mutations<br />
W. S. Kerstjens-Frederikse, R. M. F. Berger, Y. J. Vos, R. M. W. H<strong>of</strong>stra;<br />
University Medical Center, Groningen, The Netherlands.<br />
Left ventricular outflow tract obstructions (LVOTO) are <strong>of</strong>ten familial.<br />
Early detection <strong>of</strong> (latent) LVOTO or increased familial risk can prevent<br />
unexpected cardiac death . To analyse the percentage <strong>of</strong> familial cases<br />
all new and known patients with left sided anomalies seen after april 1 st<br />
2006 by the department <strong>of</strong> pediatric cardiology (170) were <strong>of</strong>fered genetic<br />
counselling . Thirty-one patients refused genetic counseling, the<br />
others were seen by the same clinical geneticist . In 44 an aortic valve<br />
stenosis was diagnosed, in 21 a bicuspid aortic valve without stenosis,<br />
in 28 a hypoplastic left heart, in 67 an aortic coarctation and in 10 other<br />
left sided anomalies . In 17 patients the family history combined with<br />
ultrasound <strong>of</strong> first degree relatives revealed a LVOTO and in another<br />
19 probands a relative with yet another congenital heart defect was<br />
found .<br />
The first mutations in NOTCH1 were published in 2005 by Garg et<br />
al . in two families with bicuspid aortic valve and other heart defects,<br />
and so far two small series showed mutations in approximately 4% <strong>of</strong><br />
the patients. In our patient group, sequencing has been finished in 40<br />
patients, and 3 mutations have been found .<br />
We conclude that LVOTO is <strong>of</strong>ten familial and most pedigrees are<br />
compatible with autosomal dominant inheritance with incomplete penetrance<br />
. NOTCH1 mutations are found in a small percentage <strong>of</strong> familial<br />
and non-familial cases .<br />
P01.244<br />
Asymptomatic neurocutaneous melanosis: A case report and<br />
review <strong>of</strong> literature<br />
N. O. Dávalos 1,2 , V. M. Anguiano-Alvarez 3 , G. H. Galicia-Hernandez 3 , R.<br />
E´Vega 3,4 , D. A. Guzmán-Sánchez 5 , M. Gonzalez-Cruz 6 , M. E. Sánchez-Castellanos<br />
7 , J. C. Salas-Alanis 3 ;<br />
1 Instituto de Genética <strong>Human</strong>a, CUCS, Universidad de Guadalajara, Gudalajara,<br />
Mexico, 2 Hospital Valentin Gomez Farias, Servicio de Genética, ISSSTE.<br />
Guadalajara, Jalisco, México., Guadalajara, Mexico, 3 Instituto de Genética Hu-